Monopar Therapeutics Inc. Stock Forecast
Big movements in Monopar Therapeutics Inc. stock price on Friday moving 19.05% between high and low
(Updated on May 10, 2024)
The Monopar Therapeutics Inc. stock price fell by -5.47% on the last day (Friday, 10th May 2024) from $0.711 to $0.672. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 19.05% from a day low at $0.630 to a day high of $0.750. The price has fallen in 6 of the last 10 days but is still up by 2.13% over the past 2 weeks. Volume has increased on the last day by 84 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 131 thousand shares were bought and sold for approximately $87.81 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.44% during the next 3 months and, with a 90% probability hold a price between $0.212 and $1.17 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
MNPR Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Monopar Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.725 and $0.682. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, February 26, 2024, and so far it has fallen -50.21%. Further fall is indicated until a new bottom pivot has been found. Monopar Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Monopar Therapeutics Inc. stock
Monopar Therapeutics Inc. finds support from accumulated volume at $0.669 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.120 between high and low, or 19.05%. For the last week, the stock has had daily average volatility of 11.74%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (MNPR) For The Upcoming Trading Day Of Monday 13th
For the upcoming trading day on Monday, 13th we expect Monopar Therapeutics Inc. to open at $0.684, and during the day (based on 14 day Average True Range), to move between $0.594 and $0.750, which gives a possible trading interval of +/-$0.0780 (+/-11.60%) up or down from last closing price. If Monopar Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 23.19% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.669 (0.48%) than the resistance at $0.761 (13.27%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Monopar Therapeutics Inc. stock A Buy?
Monopar Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Current score: -5.532 Strong Sell Candidate Downgraded
Predicted Opening Price for Monopar Therapeutics Inc. of Monday, May 13, 2024
| Fair opening price May 13, 2024 | Current price |
|---|---|
| $0.684 ( 1.77%) | $0.672 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for MNPR
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.80 | 19.62 % | |
| R2 | 0.758 | 12.80 % | ||
| R1 | 0.730 | 8.58 % | ||
| Current price: | 0.672 | |||
| Support | S1 | 0.638 | -5.05 % | |
| S2 | 0.610 | -9.27 % | ||
| S3 | 0.564 | -16.09 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.83 | 23.48 % | |
| R2 | 0.770 | 14.55 % | ||
| R1 | 0.761 | 13.27 % | ||
| Current price | 0.672 | |||
| Support | S1 | 0.669 | -0.476% | |
| S2 | 0.640 | -4.79% | ||
| S3 | 0.570 | -15.20% |
FAQ
Click here for our free guide on how to buy Monopar Therapeutics Inc. Stock.
